Cargando…
A novel autoantibody targeting calreticulin is associated with cancer in patients with idiopathic inflammatory myopathies
OBJECTIVES: To investigate the prevalence and clinical significance of anti‐calreticulin autoantibodies (anti‐CRT Ab) in a large cohort of idiopathic inflammatory myopathy (IIM) patients. METHODS: Sera from 469 patients with IIM, 196 patients with other connective tissue diseases, 28 patients with s...
Autores principales: | Chen, He, Yang, Heng, Cheng, Qiu‐Xiang, Ge, Yong‐Peng, Peng, Qing‐Lin, Zhang, Ya‐Mei, Cheng, Gen‐Hong, Wang, Guo‐Chun, Lu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558046/ https://www.ncbi.nlm.nih.gov/pubmed/33082955 http://dx.doi.org/10.1002/cti2.1195 |
Ejemplares similares
-
Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies
por: Stuhlmüller, Bruno, et al.
Publicado: (2019) -
Narrative review of autoantibodies in idiopathic inflammatory myopathies
por: Liu, Yilin, et al.
Publicado: (2021) -
The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Rider, Lisa G., et al.
Publicado: (2013) -
Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
por: Yoshifuji, Hajime
Publicado: (2016) -
Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies
por: Leclair, Valérie, et al.
Publicado: (2023)